(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 0.42% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.5%.
Anika Therapeutics's revenue in 2025 is $119,907,000.On average, 2 Wall Street analysts forecast ANIK's revenue for 2025 to be $1,601,887,322, with the lowest ANIK revenue forecast at $1,601,887,322, and the highest ANIK revenue forecast at $1,601,887,322. On average, 2 Wall Street analysts forecast ANIK's revenue for 2026 to be $1,716,925,513, with the lowest ANIK revenue forecast at $1,695,874,162, and the highest ANIK revenue forecast at $1,737,976,864.
In 2027, ANIK is forecast to generate $1,822,465,789 in revenue, with the lowest revenue forecast at $1,822,465,789 and the highest revenue forecast at $1,822,465,789.